Try our beta test site

Assessing Normal Multichannel Intraluminal Impedance (MII)-pH Parameters for Today's Population

This study has been terminated.
(unable to meet recruitment goals)
Sponsor:
Information provided by (Responsible Party):
Michael Vaezi, Vanderbilt University Medical Center
ClinicalTrials.gov Identifier:
NCT01566383
First received: March 26, 2012
Last updated: February 21, 2017
Last verified: February 2017
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: August 27, 2013
  Primary Completion Date: August 27, 2013 (Final data collection date for primary outcome measure)